Suppr超能文献

慢性阻塞性肺疾病(COPD)中产β-内酰胺酶细菌与患者特征之间的关系。

Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).

作者信息

Sportel J H, Koëter G H, van Altena R, Löwenberg A, Boersma W G

机构信息

Department of Pulmonary Diseases, University Hospital, Groningen, The Netherlands.

出版信息

Thorax. 1995 Mar;50(3):249-53. doi: 10.1136/thx.50.3.249.

Abstract

BACKGROUND

In addition to bronchodilator and anti-inflammatory therapy, exacerbations in patients with chronic obstructive pulmonary disease (COPD) are often treated with antibiotics. Haemophilus influenzae and Moraxella (Branhamella) catarrhalis, two important respiratory pathogens, may produce beta-lactamase which makes them resistant to ampicillin. Surveillance studies conducted in various countries have shown an increasing incidence of these beta-lactamase producing bacteria. Although this may simply be a consequence of the increasing use of antibiotics, it is possible that other factors are important. A study was undertaken to investigate whether clinical factors are related to the presence of beta-lactamase forming bacteria in the sputum of patients with COPD.

METHODS

One hundred patients with COPD aged over 40 years were sequentially selected from an outpatient clinic on the basis of sputum culture results. Fifty had beta-lactamase positive (beta L+) and 50 had beta-lactamase negative (beta L-) bacteria in their sputum. Patients were included only if sputum culture results yielded one pathogen. The files of these patients were investigated for possible causative factors present during the two preceding years.

RESULTS

Both groups were almost identical in terms of lung function, maintenance medication, and smoking history. The total number of antibiotic courses in the beta L+ group was higher, as were individual courses of cephalosporins, tetracyclines, and macrolides. The number of patients admitted to hospital was higher in the beta L+ group, but admissions were of equal duration in both groups. Patients admitted to hospital had poorer lung function. Risk factors for beta-lactamase producing bacteria were identified by logistic regression analysis which revealed an odds ratio for one course of antibiotics of 1.15 (95% CI 1.04 to 1.28).

CONCLUSIONS

An increased number of antibiotic courses is related to a higher incidence of beta-lactamase producing bacteria and more patients had hospital admissions in the beta L+ group. beta-lactamase stable antibiotics were used more frequently in the beta L+ group, probably because prescribing was adapted to the presence of beta-lactamase producing bacteria. No other differences were found between the beta L+ and beta L- groups.

摘要

背景

除支气管扩张剂和抗炎治疗外,慢性阻塞性肺疾病(COPD)患者的病情加重常使用抗生素治疗。流感嗜血杆菌和卡他莫拉菌(布兰汉菌属)这两种重要的呼吸道病原体可产生β-内酰胺酶,使其对氨苄西林耐药。各国进行的监测研究表明,这些产β-内酰胺酶细菌的发病率在上升。虽然这可能仅仅是抗生素使用增加的结果,但其他因素也可能很重要。开展了一项研究以调查临床因素是否与COPD患者痰液中产β-内酰胺酶细菌的存在有关。

方法

根据痰培养结果,从门诊依次选取100例年龄超过40岁的COPD患者。50例患者痰液中有产β-内酰胺酶阳性(βL+)细菌,50例患者痰液中有产β-内酰胺酶阴性(βL-)细菌。仅当痰培养结果产生一种病原体时才纳入患者。调查这些患者的病历,以寻找前两年期间可能的致病因素。

结果

两组在肺功能、维持用药和吸烟史方面几乎相同。βL+组的抗生素疗程总数更高,头孢菌素、四环素和大环内酯类药物的个别疗程数也更高。βL+组住院患者数量更多,但两组的住院时间相同。住院患者的肺功能较差。通过逻辑回归分析确定了产β-内酰胺酶细菌的危险因素,结果显示一个抗生素疗程的比值比为1.15(95%置信区间为1.04至1.28)。

结论

抗生素疗程数量增加与产β-内酰胺酶细菌的发病率较高有关,βL+组有更多患者住院。βL+组更频繁地使用对β-内酰胺酶稳定的抗生素,这可能是因为处方是根据产β-内酰胺酶细菌的存在情况调整的。βL+组和βL-组之间未发现其他差异。

相似文献

3
Clinical features of patients with beta-lactamase producing Haemophilus influenzae isolated from sputum.
J Antimicrob Chemother. 1996 Nov;38(5):881-4. doi: 10.1093/jac/38.5.881.
8
Production of betalactamase by respiratory tract bacteria in children: relationship to antibiotic use.
Scand J Prim Health Care. 1992 Mar;10(1):16-20. doi: 10.3109/02813439209014029.

本文引用的文献

2
Bacteriology of bronchitis.支气管炎的细菌学
Proc R Soc Med. 1956 Oct;49(10):773-6.
4
[Current viewpoints concerning antibiotic treatment in COPD patients].
Ned Tijdschr Geneeskd. 1994 Jul 9;138(28):1413-7.
9
Pneumococcal typing and the problem of endogenous or exogenous reinfection in chronic bronchitis.
Lancet. 1971 Jun 5;1(7710):1156-9. doi: 10.1016/s0140-6736(71)91663-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验